Bioequivalence study of generic nirmatrelvir in healthy volunteers

Bioequivalence study of generic nirmatrelvir in healthy volunteers

Nirmatrelvir is an antiviral drug that, in combination with ritonavir, is an effective agent for the etiotropic therapy of patients with mild to moderate COVID-19.The aim of the study was to evaluate bioequivalence of the generic drug nirmatrelvir Аrpaxel in combination with ritonavir and the origin...

Full description

Saved in:
Bibliographic Details
Main Authors: R. A. Oseshnyuk, A. G. Nikiforova, A. Yu. Boroduleva, P. D. Sobolev, S. A. Lesnichuk, B. B. Garyaev, A. A. Abramova, V. G. Mozgovaya, O. V. Filon, A. V. Zinkovskaya, A. N. Dolgorukova, E. K. Khanonina, V. G. Ignatiev, M. Yu. Samsonov
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-05-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
covid-19
bioequivalence
pharmacokinetics
nirmatrelvir
ritonavir
generic drug
Online Access:https://www.pharmpharm.ru/jour/article/view/1259
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.pharmpharm.ru/jour/article/view/1259

Similar Items